When administered under medical supervision following appropriate evaluation, vitamin injections are generally well-tolerated
With the popularity of GLP-1s skyrocketing, the P, which stands for peptides, is having its own moment
Its FDA-approved under different names for: Type 2 diabetes management (Ozempic) Chronic weight management (Wegovy) Its typically administered via a once-weekly injection and has shown substantial weight loss results in clinical studies
The peptide repairs intestinal mucosal damage, restores tight junction integrity (addressing leaky gut), normalizes gastric emptying and intestinal motility, and protects against NSAID-induced ulcers
Regular check-ins allow for review of new symptoms, weight loss progress, and blood sugar control
Headaches have been documented in clinical trials of semaglutide and other GLP-1 medications, occurring in roughly 5-10% of patients depending on dose and duration